Maryland-based Supernus Pharmaceuticals has secured an agreement to acquire Sage Therapeutics, surpassing a competing offer from Biogen. The deal, announced today, positions Supernus to expand its neuroscience portfolio and marks a significant consolidation in the biotech sector. The acquisition is expected to close later this year, pending regulatory approvals.

Phoenix Group Holdings announced changes to its share capital and voting rights, reflecting recent transactions and updates to its corporate structure. The move aims to enhance transparency and provide investors with clearer insight into the company's governance. These updates come as part of ongoing efforts to streamline shareholder engagement and reporting.

Phoenix Copper has released its financial results for 2024, reporting solid performance and advancing developments at its Empire Mine project. The company emphasized increased revenues and ongoing operational improvements. Management cited the Empire Mine’s progress as a key driver for future growth and shareholder value in the coming quarters.